Found: 30
Select item for more details and to access through your institution.
Efficacy and safety of vorapaxar for secondary prevention in low body weight in patients with atherosclerosis: analyses from the TRA 2<sup>°</sup>P-TIMI 50 Trial.
- Published in:
- European Heart Journal: Acute Cardiovascular Care, 2021, v. 10, n. 2, p. 190, doi. 10.1177/2048872619883354
- By:
- Publication type:
- Article
Efficacy and safety of vorapaxar for secondary prevention in low body weight in patients with atherosclerosis: analyses from the TRA 2°P-TIMI 50 Trial.
- Published in:
- European Heart Journal: Acute Cardiovascular Care, 2021, p. 190, doi. 10.1177/2048872619883354
- By:
- Publication type:
- Article
Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 29, doi. 10.1111/dom.14179
- By:
- Publication type:
- Article
Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium–glucose co‐transporter 2 inhibitor therapy in DECLARE‐TIMI 58.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 6, p. 1026, doi. 10.1002/ejhf.2073
- By:
- Publication type:
- Article
Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 6, p. 895, doi. 10.1093/eurjpc/zwaa143
- By:
- Publication type:
- Article
Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome.
- Published in:
- European Journal of Preventive Cardiology, 2018, v. 25, n. 8, p. 830, doi. 10.1177/2047487318763897
- By:
- Publication type:
- Article
Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in theTRA 2°P-TIMI 50 trial.
- Published in:
- Clinical Cardiology, 2023, v. 46, n. 3, p. 348, doi. 10.1002/clc.23972
- By:
- Publication type:
- Article
Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2°P‐TIMI 50 trial.
- Published in:
- Clinical Cardiology, 2022, v. 45, n. 8, p. 831, doi. 10.1002/clc.23843
- By:
- Publication type:
- Article
Epidemiology and Management of ST-Segment-Elevation Myocardial Infarction in Patients With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry.
- Published in:
- Journal of the American Heart Association, 2022, v. 11, n. 9, p. 1, doi. 10.1161/JAHA.121.024451
- By:
- Publication type:
- Article
Efficacy and Safety of Vorapaxar by Intensity of Background Lipid-Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P-TIMI 50 Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P-TIMI 50.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial
- Published in:
- Journal of the American Heart Association, 2017, v. 6, n. 10, p. 1, doi. 10.1161/JAHA.117.005637
- By:
- Publication type:
- Article
Short Sleep Duration, Obstructive Sleep Apnea, Shiftwork, and the Risk of Adverse Cardiovascular Events in Patients After an Acute Coronary Syndrome.
- Published in:
- Journal of the American Heart Association, 2017, v. 6, n. 10, p. 1, doi. 10.1161/JAHA.117.006959
- By:
- Publication type:
- Article
Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and safety of more potent antiplatelet therapy with vorapaxar in patients with impaired renal function.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2019, v. 47, n. 3, p. 353, doi. 10.1007/s11239-018-1779-y
- By:
- Publication type:
- Article
Vorapaxar for secondary prevention in the elderly with peripheral artery disease: Insights from the TRA 2°P-TIMI 50 trial.
- Published in:
- Vascular Medicine, 2019, v. 24, n. 2, p. 159, doi. 10.1177/1358863X19826681
- By:
- Publication type:
- Article
Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen and Dose: Post Hoc Analyses From DECLARE-TIMI 58.
- Published in:
- Diabetes Care, 2023, v. 46, n. 1, p. 156, doi. 10.2337/dc22-1318
- By:
- Publication type:
- Article
Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial.
- Published in:
- Diabetes Care, 2022, v. 45, n. 10, p. 2350, doi. 10.2337/dc22-0382
- By:
- Publication type:
- Article
Association of Baseline HbA1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58.
- Published in:
- Diabetes Care, 2022, v. 45, n. 4, p. 938, doi. 10.2337/dc21-1744
- By:
- Publication type:
- Article
A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Emotion displays in media: a comparison between American, Romanian, and Turkish children's storybooks.
- Published in:
- Frontiers in Psychology, 2014, v. 5, p. 1, doi. 10.3389/fpsyg.2014.00600
- By:
- Publication type:
- Article
Emotion Displays in Media: A Comparison Between American, Romanian, and Turkish Children's Storybooks.
- Published in:
- Frontiers in Psychology, 2014, v. 5, p. 1, doi. 10.3389/fpsyg.2014.00600
- By:
- Publication type:
- Article
788-P: The Cardiovascular and Renal Benefits of Dapagliflozin Are Independent of Baseline HbA1c: Analyses from DECLARE-TIMI 58.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-788-P
- By:
- Publication type:
- Article
303-OR: Effect of Dapagliflozin on Risk for Fast Decline in EGFR: Analyses from the DECLARE-TIMI 58 Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-303-OR
- By:
- Publication type:
- Article
1101-P: Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents: Analyses from DECLARE-TIMI 58.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1101-P
- By:
- Publication type:
- Article
244-OR: Effects of Dapagliflozin on the Urinary Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes: A Predefined Analysis from the DECLARE-TIMI 58 Randomised, Placebo-Controlled Trial.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-244-OR
- By:
- Publication type:
- Article